Keyphrases
Weight Management
100%
Liraglutide 3.0 Mg
100%
Placebo
100%
Health-related Quality of Life
100%
Short Form 36 (SF-36)
83%
Obesity
33%
Pre-diabetes (pre-DM)
16%
Once-daily
16%
Treatment Difference
16%
Exercise Program
16%
Health Impact
16%
Obesity Body Mass Index
16%
Negative Impact
16%
Comorbidity
16%
Body Mass Index
16%
Patients with Obesity
16%
Medicine and Dentistry
Weight Management
100%
Quality of Life
100%
Liraglutide
100%
Placebo
100%
Short Form 36
55%
Body Mass Index
22%
Patient with Obesity
11%
Obesity
11%
Comorbidity
11%
Impaired Glucose Tolerance
11%
Pharmacology, Toxicology and Pharmaceutical Science
Liraglutide
100%
Placebo
100%
Comorbidity
16%
Obesity
16%
Impaired Glucose Tolerance
16%
Immunology and Microbiology
Body Mass
100%
Comorbidity
50%